Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant hepatic arterial infusion pump chemotherapy after repeat hepatectomy for recurrent colorectal liver metastases
NL-OMON50045Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of floxuridine in colorectal cancer liver metastasis (CRLM), sponsored by Erasmus MC. Primary endpoint: hepatic progression-free survival. Started Mar 2021; status: recruiting.
02
Drugs
floxuridine
03
Conditions
colorectal cancer liver metastasis (CRLM)
Beyond the preview
Go deeper on NL-OMON50045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50045.